Easywell Biomedicals, Inc.

TPEX:1799 Voorraadrapport

Marktkapitalisatie: NT$13.0b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Easywell Biomedicals Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

James Aiping Lee

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO3.4%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Feb 12
What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

CEO

James Aiping Lee

no data

Tenure

Mr. James Aiping Lee, Ph D, is President of Easywell Biomedicals, Inc and serves as its Manager. He has extensive experience in both medical device and pharmaceutical industries.As the founder of Magnific...